CSL Behring

CSL Behring

IL - Bradley
Biotechnology10 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Biologics

CSL Behring is a life sciences company focused on Biologics.

Rare DiseasesNeurologyInfectious DiseasesNephrologyCardiovascular
Open Jobs
0

Products & Portfolio (1)

ANDEMBRY
garadacimab
Launch
mAbSUBCUTANEOUS · INJECTABLE
Garadacimab-gxii is an inhibitor of activated FXII that binds to the catalytic domain of activated Factor XII (FXIIa and βFXIIa) and inhibits its catalytic activity. FXII is the first factor activated in the contact activation pathway and initiates the inflammatory bradykinin-producing kallikrein-kinin system. The inhibition of FXIIa decreases the activation of prekallikrein to kallikrein and the generation of bradykinin, which is associated with inflammation and swelling in HAE attacks, thus reducing the cascade of events leading to an HAE attack.
2025
30

Pipeline & Clinical Trials

Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013
Hemophilia
N/A
Clinical Trials (1)
NCT02546622ATHN 2: Factor Switching Study
N/A
IVIg
CIDP
N/A
Clinical Trials (1)
NCT05614128Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
N/A
FVIII Concentrates
Severe Hemophilia A
N/A
subcutaneous immunoglobulin
Hypogammaglobulinemia
N/A
Clinical Trials (1)
NCT03401268Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients
N/A
AAV5-hFIXco-Padua
Hemophilia B
N/A
Clinical Trials (1)
NCT05962398Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
N/A
N/A
Clinical Trials (1)
NCT02540005Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage
N/A
Respreeza® Self-administration and Learning Program (AmAREtTI Study)
Alpha-1 Antitrypsin Deficiency
N/A
Clinical Trials (1)
NCT04262284Respreeza® Self-administration and Learning Program (AmAREtTI Study)
N/A
Observatory of Patients With Haemophilia B Treated by IdElvion®
Haemophilia B
N/A
Clinical Trials (1)
NCT05086575Observatory of Patients With Haemophilia B Treated by IdElvion®
N/A
VWF/FVIII concentrates
Severe Hemophilia A
N/A
Quality of Life Study of Helixate NexGen
Hemophilia A
N/A
Clinical Trials (1)
NCT01053715Quality of Life Study of Helixate NexGen
N/A
The German Patient Blood Management Network
Clinical Safety of a PBM Program
N/A
Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury
Acute Kidney Injury
N/A
Clinical Trials (1)
NCT06471621Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury
N/A
N/A
Clinical Trials (1)
NCT02427217An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency
N/A
N/A
Clinical Trials (1)
NCT04672733Hizentra® in Inflammatory Neuropathies - pHeNIx Study
N/A
N/A
Clinical Trials (1)
NCT04657887Registry of Patients With Von WilLEbrand Disease Treated With Voncento®
N/A
Rabies Vaccine
Rabies
N/A
Clinical Trials (1)
NCT01063140Rabies Immune Plasma Booster Study
N/A
Blood collection
Ataxia Telangiectasia
N/A
Clinical Trials (1)
NCT02345135Susceptibility to Infections in Ataxia Telangiectasia
N/A
A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)
Von Willebrand Disease
N/A
Clinical Trials (1)
NCT00701545A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)
N/A
Kcentra®
Hemorrhage
N/A
Clinical Trials (1)
NCT02319460An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding
N/A
CSL830
Various
N/A
Clinical Trials (1)
NCT03177005Expanded Access for Hereditary Angioedema (HAE)
N/A
HEMGENIX
Hemophilia B
N/A
Clinical Trials (1)
NCT06008938An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
N/A
Afstyla®
Haemophilia A
N/A
Clinical Trials (1)
NCT04675541Register of Patients With haEmophilia A tReated With Afstyla®
N/A
N/A
Clinical Trials (1)
NCT01108848Patient Registry Study of Berinert® in Normal Clinical Practice
N/A
questionnaire survey
Immune Deficiency, Antibody
N/A
Clinical Trials (1)
NCT02542228Construction of a Health-related Quality of Life (HR-QOL) Questionnaire for Patients With Primary Antibody Deficiency Disease
N/A
N/A
Clinical Trials (1)
NCT03779828Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP
N/A
No intervention
Hereditary Angioedemas
N/A
Clinical Trials (1)
NCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
N/A
N/A
Clinical Trials (1)
NCT01053169Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)
N/A
Immunological diagnosis tests
Complement Deficiency
N/A
N/A
Clinical Trials (1)
NCT01361178Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement
N/A
N/A
Clinical Trials (1)
NCT01785056IVIG Treatment in Systemic Sclerosis
N/A
N/A
Clinical Trials (1)
NCT02414490IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
N/A
N/A
Clinical Trials (1)
NCT01166074Retrospective Chart Review of Subcutaneous IgG Use in Infants
N/A
N/A
Clinical Trials (1)
NCT02810327Alpha-1 Carrier Genomics Study
N/A
AAV5-hFIX
Hemophilia B
N/A
Clinical Trials (1)
NCT05360706Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B
N/A
mgt of bleeding concerns/complications of oral anticoagulants
Blood Coagulation
N/A
N/A
Clinical Trials (1)
NCT02915614Effects of Pulmonary Rehabilitation on Skeletal Muscle in COPD Patients
N/A
N/A
Clinical Trials (1)
NCT02465359Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
N/A
N/A
Clinical Trials (1)
NCT00661401Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin
N/A
Health Related Quality of Life of Youth and Young Adults With Hemophilia A
Hemophilia A
N/A
Clinical Trials (1)
NCT01034904Health Related Quality of Life of Youth and Young Adults With Hemophilia A
N/A
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Hemophilia
N/A
N/A
Clinical Trials (1)
NCT05452317Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection
N/A
Australian and New Zealand Massive Transfusion Registry
Massive Transfusion
N/A
Clinical Trials (1)
NCT02863250Australian and New Zealand Massive Transfusion Registry
N/A
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Hematologic Disorder
N/A
VWF/FVIII products
Von Willebrand Disease
N/A
Clinical Trials (1)
NCT00557908The Von Willebrand Disease (VWD) International Prophylaxis Study
N/A
N/A
Clinical Trials (1)
NCT07159464Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study
N/A
Vitamin D and calcium
Hemophilia A
N/A
Clinical Trials (1)
NCT01090206Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia
N/A
Joint Health Study
Hemophilia B
N/A
Clinical Trials (1)
NCT03358836Joint Health Study
N/A
National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
Von Willebrand Disease
N/A
Clinical Trials (1)
NCT00510042National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
N/A
Additional blood sampling at the same time and in addition of samplings already done for the patient's standard of care.
Liver Cirrhosis
N/A
Clinical Trials (1)
NCT06050993Effects of Platelet Mimicking Nanoparticles in Patients With Cirrhosis
N/A
Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients
Surgery
N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 1 approved product, 142 clinical trials
Top TAs: Rare Diseases, Neurology, Nephrology
H-1B (2023): 10 approvals
Portfolio Health
Launch1 (100%)
1 total products
Therapeutic Area Focus
Rare Diseases
36 pipeline
Neurology
14 pipeline
Nephrology
9 pipeline
Cardiovascular
7 pipeline
Respiratory
7 pipeline
Immunology
5 pipeline
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
10
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub